Covaxin true example of public-private partnership: ICMR Chief MD Bureau24 Nov 2021 12:17 PM ISTNew Delhi: The development of India's indigenous vaccine -- Covaxin, is a true example of public-private partnership marked with trust and and...
Serum Institute seeks Govt to fast-track Covishield movement Ruchika Sharma23 Nov 2021 12:20 PM ISTNew Delhi: Serum Institute of India (SII) has urged the government to fast-track Covishield movement citing the difficulties being faced in production...
AstraZeneca's antibody shot 83% effective at preventing Covid MD Bureau21 Nov 2021 10:00 AM ISTLondon: A single shot of an antibody treatment against Covid-19 developed by UK drug major AstraZeneca is 83 per cent capable to reduce the risk of...
Covid-19: Akston Biosciences doses first subjects in AKS-452 study Ruchika Sharma21 Nov 2021 9:45 AM ISTBeverly: Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, has announced that the first of 100 subjects...
USFDA authorizes Moderna COVID vaccine booster shots for all adults Ruchika Sharma20 Nov 2021 3:43 PM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has recently announced that the U.S....
PM Modi inaugurates first Global Innovation Summit of Pharma Sector Ruchika Sharma20 Nov 2021 10:00 AM ISTNew Delhi: The Prime Minister, Shri Narendra Modi has inaugurated the first Global Innovation Summit of the Pharmaceuticals sector. Union Minister Dr....
SII, Novavax get emergency use nod for COVID vaccine in Philippines Ruchika Sharma18 Nov 2021 12:51 PM ISTPune: Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII) have recently announced that the Philippine Food and Drug Administration (FDA)...
Phase 3 data shows Covaxin 77.8 percent effective against COVID: Lancet Roshni Dhar16 Nov 2021 4:05 PM ISTBharat Biotech has recently announced that the safety and efficacy analysis data from Phase III clinical trials of COVAXIN is peer reviewed and...
Covaxin has cellular immune memory to COVID for at least 6 months: NII Ruchika Sharma16 Nov 2021 1:21 PM ISTNew Delhi: Bharat Biotech's Covaxin has immunological memory to Covid and its variants of concern for at least up to six months, National...
Serum Institute allowed to export 5 crore Covovax doses to Indonesia Ruchika Sharma16 Nov 2021 11:00 AM ISTNew Delhi: The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum...
AstraZeneca begins to earn mild profit from Covid-19 vaccine Ruchika Sharma15 Nov 2021 3:37 PM ISTNew Delhi: AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the...
Zydus Cadila ZyCov-D to be administered only to adults: Report Ruchika Sharma15 Nov 2021 3:33 PM ISTNew Delhi: Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be...
